In addition, genetic deletion of the B cell transcription factor Pax5 in CD23-expressing cells (primarily mature B2 cells) (55), or treatment with an agonistic antibody specific for B- and T-lymphocyte attenuator (56) that reduced mature B-2 cells, also resulted in decreased atherosclerosis. The gene discussed is PAX5; the disease is atherosclerosis.